Barclays Cuts Definitive Healthcare (NASDAQ:DH) Price Target to $1.00

Definitive Healthcare (NASDAQ:DH) had its price objective trimmed by Barclays from $2.75 to $1.00 in a report published on Monday morning,Benzinga reports. The firm currently has an underweight rating on the stock.

Several other research firms also recently issued reports on DH. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Definitive Healthcare in a research note on Wednesday, January 21st. Morgan Stanley reissued an “underperform” rating and issued a $3.50 price objective on shares of Definitive Healthcare in a research note on Thursday, December 18th. Canaccord Genuity Group dropped their target price on shares of Definitive Healthcare from $4.00 to $3.00 and set a “hold” rating for the company in a report on Friday, February 27th. Zacks Research cut shares of Definitive Healthcare from a “hold” rating to a “strong sell” rating in a research report on Thursday, March 5th. Finally, Stephens reduced their price target on shares of Definitive Healthcare from $3.00 to $2.00 and set an “equal weight” rating on the stock in a report on Friday, February 27th. One analyst has rated the stock with a Strong Buy rating, one has issued a Buy rating, four have issued a Hold rating and four have issued a Sell rating to the company. Based on data from MarketBeat.com, Definitive Healthcare presently has an average rating of “Reduce” and an average target price of $3.27.

Definitive Healthcare Stock Performance

Shares of DH stock opened at $1.09 on Monday. The stock has a fifty day moving average price of $1.53 and a 200 day moving average price of $2.42. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.64 and a current ratio of 1.64. The stock has a market cap of $113.87 million, a PE ratio of -0.87 and a beta of 1.60. Definitive Healthcare has a 1 year low of $0.97 and a 1 year high of $4.70.

Institutional Trading of Definitive Healthcare

Large investors have recently made changes to their positions in the stock. Bayesian Capital Management LP acquired a new position in Definitive Healthcare in the 2nd quarter valued at about $55,000. HRT Financial LP acquired a new stake in shares of Definitive Healthcare during the 4th quarter worth about $47,000. ExodusPoint Capital Management LP purchased a new stake in shares of Definitive Healthcare during the fourth quarter worth about $47,000. Raymond James Financial Inc. purchased a new stake in shares of Definitive Healthcare during the second quarter worth about $32,000. Finally, Jefferies Financial Group Inc. acquired a new position in shares of Definitive Healthcare in the fourth quarter valued at approximately $144,000. Institutional investors and hedge funds own 98.67% of the company’s stock.

Definitive Healthcare Company Profile

Definitive Healthcare (NASDAQ:DH) is a leading provider of intelligence and analytics on healthcare providers, organizations and the professionals who treat patients. Through its cloud-based platform, the company aggregates data from multiple sources—including claims, government registries, commercial filings and proprietary research—to deliver a unified view of the healthcare landscape. Its solutions enable life sciences companies, healthcare providers, payers and consulting firms to identify market opportunities, optimize sales and marketing efforts, improve operational efficiency and support better patient outcomes.

The company’s flagship offering is a subscription-based data platform that features detailed profiles on physicians, hospitals, health systems and post-acute care facilities.